Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 390

Neoadjuvant T-VEC in High Risk Early Melanoma

Neoadjuvant T-VEC in High Risk Early Melanoma
Condition:   Melanoma
Intervention:   Drug: T-Vec
Sponsors:   University of California, Davis;   Amgen

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 12, 2020 / by / in